Activity of amikacin against Mycobacterium avium complex under simulated in vivo conditions.
AUTOR(ES)
Gangadharam, P R
RESUMO
We studied the activity of amikacin against Mycobacterium avium complex strain 101 by using continuous-level, changing concentrations which simulated levels in serum in a patient, and pulsed exposures. Amikacin at a concentration of 5 or 15 micrograms/ml showed rapid bactericidal action following constant exposure of the organisms. With the in vitro model, using a peak concentration of 10 or 20 micrograms/ml, complete sterilization was obtained by day 7. In pulsed-exposure studies, a minimum period of contact of 72 or 96 h at a concentration of 10 micrograms/ml was needed for complete sterilization.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=172301Documentos Relacionados
- In vitro activity of amikacin against Mycobacterium avium.
- Comparative activities of amikacin against Mycobacterium avium complex in nude and beige mice.
- In vivo activity of amikacin alone or in combination with clofazimine or rifabutin or both against acute experimental Mycobacterium avium complex infections in beige mice.
- Antimycobacterial Activity of Rifampin Under In Vitro and Simulated In Vivo Conditions
- Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine.
